Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced that the U.S.
Arrowhead Research Corp On September 24, 2015 shares of Arrowhead Research Corp (NASDAQ:ARWR) were up as much as 20% after announcing positive phase …
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)’s weekly options are pricing in a move of +/- $10 with Implied VOL currently in the 28th percentile over …
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) excited Wall Street on July 2 after the company announced that the U.S.
Canaccord Genuity analyst Adam Walsh weighed in with an optimistic view on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), reiterating a Buy recommendation on the stock with …
Orexigen Therapeutics, Inc. (NASDAQ:OREX) On May 12, 2015 Shares of Orexigen tanked by 13% after the company reported that the cardiovascular outcome study had …
The FDA advisory committee recommended this week that the FDA approve Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)’s Orkambi therapy to treat cystic fibrosis. By a vote …
On May 12, the FDA advisory committee recommended that the FDA approve Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)’s Orkambi therapy to treat cystic fibrosis. Shares of …
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares are up 8% in after-market trading after the FDA’s advisory committee panel recommended for approval the company’s ORKAMBI cystic fibrosis treatment. By …
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) weekly options are pricing in a move of +/- $10 with Implied VOL currently in the 28th percentile over the …
